Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Foodborne Pathog Dis ; 16(2): 119-129, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30277811

RESUMO

Ruminants are important reservoirs of E. coli O157:H7 and are considered as the major source of most foodborne outbreaks (e.g., 2017 outbreak in Germany, 2014 and 2016 outbreaks in United States, all linked to beef products). A promising strategy to reduce E. coli O157 is using antimicrobials to reduce the pathogen levels and/or virulence within the animal gastrointestinal tract and thus foodborne disease. The aim of the study was to determine the efficacy of a commercial mixture of natural antimicrobials against E. coli O157. The minimum inhibitory concentration and minimum bactericidal concentration of the antimicrobial were quantitatively determined and found to be 0.5% and 0.75% (v/v) of the natural antimicrobial, respectively. Microbial growth kinetics was also used to determine the effect of the antimicrobial on the pathogen. The natural antimicrobial affected the cell membrane of E. coli O157, as demonstrated by the increase in relative electric conductivity and increase in protein and nucleic acid release. The antimicrobial was also able to significantly reduce the concentration on E. coli O157 in a model rumen system. Biofilm assays showed that subinhibitory concentrations of the antimicrobial significantly reduced the E. coli 0157 biofilm forming capacity without influencing pathogen growth. In addition, the natural antimicrobial was able to reduce motility and exopolysaccharide production. Subinhibitory concentrations of the antimicrobial had no effect on AI-2 production. These findings suggest that the natural antimicrobial exerts an antimicrobial effect against E. coli O157 in vitro and in a model rumen system and could be potentially used to control this pathogen in the animal gut. The results also indicate that subinhibitory concentrations of the antimicrobial effectively reduce biofilm formation, motility, and exopolysaccharide production.


Assuntos
Anti-Infecciosos/farmacologia , Produtos Biológicos/farmacologia , Escherichia coli O157/efeitos dos fármacos , Animais , Biofilmes/efeitos dos fármacos , Biofilmes/crescimento & desenvolvimento , Bovinos , Permeabilidade da Membrana Celular , Condutividade Elétrica , Escherichia coli O157/crescimento & desenvolvimento , Escherichia coli O157/fisiologia , Feminino , Homosserina/análogos & derivados , Homosserina/efeitos dos fármacos , Humanos , Lactonas , Testes de Sensibilidade Microbiana , Polissacarídeos Bacterianos/metabolismo , Rúmen/efeitos dos fármacos , Rúmen/microbiologia
2.
Appl Environ Microbiol ; 82(22): 6531-6540, 2016 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-27590808

RESUMO

This study evaluated the inhibitory effect of cinnamon oil against Escherichia coli O157:H7 Shiga toxin (Stx) production and further explored the underlying mechanisms. The MIC and minimum bactericidal concentration (MBC) of cinnamon oil against E. coli O157:H7 were 0.025% and 0.05% (vol/vol), respectively. Cinnamon oil significantly reduced Stx2 production and the stx2 mRNA expression that is associated with diminished Vero cell cytotoxicity. Consistently, induction of the Stx-converting phage where the stx2 gene is located, along with the total number of phages, decreased proportionally to cinnamon oil concentration. In line with decreased Stx2 phage induction, cinnamon oil at 0.75× and 1.0× MIC eliminated RecA, a key mediator of SOS response, polynucleotide phosphorylase (PNPase), and poly(A) polymerase (PAP I), which positively regulate Stx-converting phages, contributing to reduced Stx-converting phage induction and Stx production. Furthermore, cinnamon oil at 0.75× and 1.0× MIC strongly inhibited the qseBC and luxS expression associated with decreased AI-2 production, a universal quorum sensing signaling molecule. However, the expression of oxidative stress response genes oxyR, soxR, and rpoS was increased in response to cinnamon oil at 0.25× or 0.5× MIC, which may contribute to stunted bacterial growth and reduced Stx2 phage induction and Stx2 production due to the inhibitory effect of OxyR on prophage activation. Collectively, cinnamon oil inhibits Stx2 production and Stx2 phage induction in E. coli O157:H7 in multiple ways. IMPORTANCE: This study reports the inhibitory effect of cinnamon oil on Shiga toxin 2 phage induction and Shiga toxin 2 production. Subinhibitory concentrations (concentrations below the MIC) of cinnamon oil reduced Stx2 production, stx2 mRNA expression, and cytotoxicity on Vero cells. Subinhibitory concentrations of cinnamon oil also dramatically reduced both the Stx2 phage and total phage induction in E. coli O157:H7, which may be due to the suppression of RNA polyadenylation enzyme PNPase at 0.25× to 1.0× MIC and the downregulation of bacterial SOS response key regulator RecA and RNA polyadenylation enzyme PAP I at 0.75× or 1.0× MIC. Cinnamon oil at higher levels (0.75× and 1.0× MIC) eliminated quorum sensing and oxidative stress. Therefore, cinnamon oil has potential applications as a therapeutic to control E. coli O157:H7 infection through inhibition of bacterial growth and virulence factors.


Assuntos
Cinnamomum zeylanicum/química , Colífagos/efeitos dos fármacos , Escherichia coli O157/efeitos dos fármacos , Óleos Voláteis/farmacologia , Óleos de Plantas/farmacologia , Toxina Shiga II/biossíntese , Animais , Proteínas de Bactérias/efeitos dos fármacos , Proteínas de Bactérias/genética , Liases de Carbono-Enxofre/efeitos dos fármacos , Liases de Carbono-Enxofre/genética , Chlorocebus aethiops , Escherichia coli O157/crescimento & desenvolvimento , Escherichia coli O157/metabolismo , Escherichia coli O157/patogenicidade , Regulação Bacteriana da Expressão Gênica , Homosserina/análogos & derivados , Homosserina/efeitos dos fármacos , Lactonas , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/genética , Prófagos , Percepção de Quorum/efeitos dos fármacos , Resposta SOS em Genética/efeitos dos fármacos , Toxina Shiga II/genética , Células Vero , Fatores de Virulência/genética
4.
Bioorg Med Chem ; 16(4): 1596-604, 2008 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-18053731

RESUMO

The bioluminescence of the marine bacterium Vibrio harveyi is controlled by quorum sensing. This effect is mediated by production, accumulation, and auto-detection of the species-specific autoinducer 1 (AI-1), autoinducer 2 (AI-2), and the V. cholerae autoinducer 1 (CAI-1). The V. harveyi AI-2 was recently identified as furanosyl borate diester. We synthesized several oxazaborolidine derivatives that chemically resemble the structure of AI-2. Five oxazaborolidine derivatives (BNO-1 to BNO-5) were tested, however only BNO-1 (3,4-dimethyl-2,5-diphenyl-1,3,2-oxazaborolidine), and BNO-5 (2-butyl-3,4-dimethyl-5-phenyl-1,3,2-oxazaborolidine) strongly induced V. harveyi bioluminescence in V. harveyi mutant (BB170) lacking sensor 1. A dose-dependent relationship between those oxazaborolidine derivatives and bioluminescence induction was observed with this V. harveyi strain (BB170). BNO-1 and BNO-5 did not affect V. harveyi BB886 lacking sensor 2. Using a mutant strain which produces neither AI-1 nor AI-2 (V. harveyi MM77) we showed that the presence of spent medium containing AI-2 is essential for BNO-1 and BNO-5 activity. This effect was similar when introducing the spent medium and the BNOs together or at a 3-h interval. A comparable induction of bioluminescence was observed when using synthetic DPD (pre-AI-2) in the presence of BNO-1 or BNO-5. The mode of action of BNO-1 and BNO-5 on bioluminescence of V. harveyi is of a co-agonist category. BNO-1 and BNO-5 enhanced AI-2 signal transduction only in the presence of AI-2 and only via sensor 2 cascade. BNO-1 and BNO-5 are the first oxazaborolidines reported to affect AI-2 activity. Those derivatives represent a new class of borates which may become prototypes of novel agonists of quorum sensing mediated by AI-2 in V. harveyi.


Assuntos
Compostos de Boro/farmacologia , Compostos Heterocíclicos com 1 Anel/farmacologia , Homosserina/análogos & derivados , Luminescência , Oxazóis/farmacologia , Transdução de Sinais/efeitos dos fármacos , Vibrio/efeitos dos fármacos , Proteínas de Bactérias , Compostos de Boro/química , Relação Dose-Resposta a Droga , Compostos Heterocíclicos com 1 Anel/química , Homosserina/efeitos dos fármacos , Lactonas , Oxazóis/química , Percepção de Quorum , Relação Estrutura-Atividade
5.
Chemotherapy ; 45(5): 335-41, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10473921

RESUMO

Pseudomonas aeruginosa infection is preceded by selective adhesion of the bacteria to the host target cells via diverse adhesins, including lectins. This step enables maximal damage to the target host cells by the bacterially secreted injurious toxins and enzymes. The production of both lectins and many of the virulence factors is positively controlled by transcription activators including signaling autoinducers (N-acyl-L-homoserine lactones). We show in this communication that erythromycin at subminimal growth inhibitory concentrations simultaneously suppresses the production of P. aeruginosa hemagglutinins (including lectins), protease, hemolysin and homoserine lactone autoinducers. The antibiotic-treated bacteria also show reduced virulence to mice, endorsing clinical observations that indicate the efficiency of low-dose erythromycin treatment of persistent drug-resistant P. aeruginosa infections.


Assuntos
Adesinas Bacterianas/biossíntese , Eritromicina/farmacologia , Homosserina/análogos & derivados , Lactonas/metabolismo , Lectinas , Inibidores da Síntese de Proteínas/farmacologia , Pseudomonas aeruginosa/efeitos dos fármacos , Adesinas Bacterianas/efeitos dos fármacos , Animais , Antibacterianos/farmacologia , Aderência Bacteriana/efeitos dos fármacos , Relação Dose-Resposta a Droga , Resistência Microbiana a Medicamentos , Matriz Extracelular/efeitos dos fármacos , Matriz Extracelular/metabolismo , Testes de Hemaglutinação , Homosserina/efeitos dos fármacos , Homosserina/metabolismo , Humanos , Camundongos , Camundongos Endogâmicos ICR , Testes de Sensibilidade Microbiana , Pseudomonas aeruginosa/metabolismo , Pseudomonas aeruginosa/patogenicidade , Virulência/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...